| 17-May-2023 | D | Board approved:-
1. Recommended dividend of INR 8 (eight) per equity share of INR 10 each (80%) for the financial year 2022-23, subject to approval of members at the ensuing Annual General Meeting. | 13-Sep-2023 | |
| 20-May-2022 | D | The Board has recommended dividend of 100% that is INR 10 per equity share of INR 10 each for the financial year 2021-22, subject to approval of members in the ensuing Annual General Meeting.
We enclose, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, a copy of each newspaper clipping of the advertisement published on 30 July 2022 on Notice of 35th Annual General Meeting, Book Closure Period and e-voting information to Members, in Ahmedabad edition of the newspapers: Financial Express (English), and Financial Express (Gujarati).
(As Per BSE Announcement Dated on 30/07/2022) | 11-Aug-2022 | |
| 08-Jun-2021 | D | The Board of Directors has recommended dividend of 100% that is INR 10 per equity share of INR 10 each for the financial year 2020-21, subject to approval of members in the ensuing Annual General Meeting. | 05-Aug-2021 | |
| 26-Jun-2020 | D | Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings:
Recommended dividend of 66% that is INR 6.60 per equity share of INR 10 each for the financial year 2019-20, subject to approval of members in the ensuing Annual General Meeting. | 27-Aug-2020 | |
| 07-May-2019 | D | The Board of Directors recommended final dividend of 70% that is INR 7.00 per equity share for the financial year 2018-19, subject to approval of members in the ensuing Annual General Meeting. | 18-Jul-2019 | |
| 29-Oct-2018 | D | Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we
would like to inform you that Board of Directors, in their Meeting held today, have approved the followings:
The Board of Directors declared 2nd interim dividend of 20% that is INR 2.00 (two) per equity
share on the face value of INR 10 (ten) per share. The Company has already paid 1st Interim
Dividend of INR 2.00 (Two) per equity shares. | 09-Nov-2018 | |
| 10-Aug-2018 | D | The Board of Directors declared 1st interim dividend of 20% that is INR 2.00 per equity share on the face value of INR 10 (ten) per share, for the financial year 2018-19.
Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the record date is Friday, 31 August 2018 for the purpose of 1st interim dividend on the equity shares of the Company for the financial year 2018-19, as declared by the Board of Directors at their meeting held on 10 August 2018.
(As Per BSE Announcement Dated On 20/08/2018) | 30-Aug-2018 | |
| 14-May-2018 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2018, inter alia, has recommended final dividend of 60% that is INR 6 per equity share for the financial year 2017-18, subject to approval of members in the ensuing Annual General Meeting. | 02-Aug-2018 | |
| 09-Nov-2017 | D | The Board of Directors, in their Meeting held today, have approved the Unaudited Standalone Financial Results for the quarter and half year ended on 30 September 2017. The Boards of Directors have declared an interim dividend of 40%, that is INR 4 (four) per equity share on the face value of INR 10 (ten) per share, for the financial year 2017-18. | 16-Nov-2017 | |
| 08-May-2017 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2017, inter alia, has recommended final dividend of 23% that is INR 2.30 per equity share for the financial year 2016-17, subject to approval of members in the ensuing Annual General Meeting. | 20-Jul-2017 | |
| 20-Oct-2016 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 20, 2016, inter alia, has declared an interim dividend of 30%, that is INR 3 (three) per equity share on the face value of INR 10 (ten) per share, for the financial year 2016-17. | 03-Nov-2016 | |
| 07-May-2016 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2016, inter alia, have recommended final dividend of 11% that is INR 1.10 per equity share for the financial year 2015-16, subject to approval of members in the ensuing Annual General Meeting. | 21-Jul-2016 | |
| 10-Mar-2016 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, have declared the Interim Dividend of 30% that is INR 3.00 per equity share on face value of INR 10 per share, for the financial year 2015-16. | 17-Mar-2016 | |
| 28-May-2015 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, inter alia, have recommended dividend of 31%, that is Rs. 3.10 per equity share for the financial year 2014-2015, subject to approval of members in the ensuing Annual General Meeting. | 10-Sep-2015 | |
| 30-May-2014 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each (20%) for the financial year 2013-14, subject to the approval of shareholders. | 18-Sep-2014 | |
| 03-Jun-2013 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each (20%) for the financial year 2012-13, subject to the approval of shareholders. | 07-Aug-2013 | |
| 14-Aug-2012 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has approved the following matters:
1. To recommend Dividend of Re. 1/- per share on the Face value of Rs. 10/- per share (10%) for the F.Y. 2011-12. | 27-Aug-2012 | |
| 24-May-2011 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2011, inter alia, has recommended a Dividend of Rs. 3.50 per equity share of Rs. 10 each (35%) subject to approval of shareholders at the ensuing Annual General Meeting. | 25-Aug-2011 | |
| 24-May-2010 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2010, inter alia, has recommended a Dividend of Rs. 3.00 per equity share of Rs. 10 each (30%), subject to the approval of shareholders at the ensuing Annual General Meeting. | 22-Jul-2010 | |
| 30-Jun-2009 | D | Hester Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2009, inter alia, has recommended a Dividend of Rs 2.50 per equity share of Rs 10 each (25%) subject to the approval of shareholders at the ensuing Annual General Meeting.
| 13-Aug-2009 | |
| 24-Jun-2008 | D | Hester Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2008, inter alia, has recommended a Dividend of Rs 2.50 per equity share of Rs 10 each (25%), subject to the approval of shareholders at the ensuing Annual General Meeting. | 21-Aug-2008 | |
| 27-Jun-2007 | D | Hester Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2007, inter alia, has recommended a Dividend of Rs 2.00 per equity share of Rs 10 each (20%), subject to the approval of shareholders at the ensuing Annual General Meeting. | 06-Sep-2007 | |
| 22-Apr-2005 | D | 12% Dividend | 06-Jun-2005 | |
| 18-Sep-2012 | B | SUB. :- Bonus issue of Hester Biosciences Ltd. (Scrip Code: 524669)
Trading Members of the Exchange are hereby informed that Hester Biosciences Ltd. has fixed the Book Closure for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Hester Biosciences Ltd.
(524669)
BOOK CLOSURE
29/09/2012 To 29/09/2012
PURPOSE
Issue of 1 (ONE) fully paid up Bonus equity share of Rs. 10/- each for every 2 (TWO) fully paid up equity shares of Rs. 10/- each held.
Ex-Bonus basis from Date & Sett. No.
27/09/2012 DR-127/2012-2013
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 20.09.2012) | 29-Sep-2012 | 1:2 |
| 23-May-2006 | R | Trading Members of the Exchange are hereby informed that, Hester Pharmaceuticals Limited has fixed the Record Date for the purpose of Rights Issue. The transactions in the equity shares of the company should be done on an ex-rights basis with effect from the under mentioned date.
RECORD DATE 05/06/2006
TWO Equity Shares of Rs.10/- each for cash at a premium of Rs.60/- per equity share on rights basis for every FIVE existing equity shares held.
The auction in the equity shares of Hester Pharmaceuticals Limited in Dematerialised Securities - Rolling Settlement Segment on
29/05/2006, 30/05/2006 and 31/05/2006 will be conducted on cum-right basis. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity
shares of the said company in auction on the said dates.
The scrip will be in No Delivery from 29/05/2006 (DR-041/2006-2007) to 02/06/2006 (DR-045/2006-2007). | 05-Jun-2006 | 2:5 |
| 24-Jan-2024 | BC | HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve standalone and consolidated unaudited f | 02-Feb-2024 | |
| 30-Jan-2024 | BC | Oaklane Capital Management LLP
The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Oaklane Capital | 29-Jan-2024 | |
| 27-Oct-2023 | BC | HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the standalone and consolidated unaudit | 07-Nov-2023 | |
| 23-Aug-2023 | BC | Pursuant to regulation 34(1) of SEBI (LODR) Regulations, 2015, we are submitting herewith the Annual Report of the Company along with the Notice of the 36th Annual General Meeting for the financial y | 20-Sep-2023 | |
| 20-Sep-2023 | BC | Outcome of 36th Annual General Meeting held on 20 September 2023 which includes, Proceedings, Voting Results and Scrutinizer Report.
| 20-Sep-2023 | |